^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Stella Diagnostics

    i
    Other names: Stella Diagnostics | Stella Diagnostics, Inc. | Stella Diagnostics, Inc
    Related tests:
    Evidence

    News

    almost2years
    ProPhase Labs closes acquisition of BE-Smart Esophageal Pre-Cancer diagnostic screening test (ProPhase Press Release)
    "ProPhase Labs...announced it has completed its previously announced acquisition of the world-wide exclusive rights to the BE-Smart Esophageal Pre-Cancer diagnostic screening test and related intellectual property assets from Stella Diagnostics, Inc. ('Stella')."
    M&A
    |
    BE-Smart Esophageal Pre-Cancer screening test
    almost2years
    ProPhase Labs acquires rights to novel esophageal cancer test (ProPhase Press Release)
    "ProPhase Labs...today announced that it has entered into an asset purchase agreement to acquire from Stella Diagnostics, Inc. ('Stella') world-wide exclusive rights to Stella’s BE-Smart Esophageal Pre-Cancer diagnostic screening test and related intellectual property assets for approximately $4.5 million dollars, comprised of approximately $3.5 million in cash and $1 million in ProPhase common stock."
    M&A
    |
    BE-Smart Esophageal Pre-Cancer screening test
    over2years
    Stella Diagnostics and Mayo Clinic to present data on the utility of the STLA101 Test for esophageal cancer staging at the 2022 AGA Digestive Disease Week Conference (GlobeNewswire)
    "Stella Diagnostics, Inc...announced today that its abstract titled 'Markers in STLA101 Assay Detects Differential Expression to Distinguish Between Intramucosal and Invasive Esophageal Adenocarcinoma' has been selected for presentation during Digestive Disease Week (DDW) 2022, which will take place May 21–24, 2022 at the San Diego Convention Center in San Diego, CA."
    Clinical data
    |
    STLA101 Test
    over2years
    Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
    "Stella Diagnostics, Inc...announced it will be giving a data presentation this week at the American Association for Cancer Research (AACR) Annual Meeting, which is being held April 8 – 13, 2022, at the Ernest N. Morial Convention Center in New Orleans, LA."
    Clinical data